<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2001-06-20" modified="2020-10-07" version="202">
<accession>Q9BZS1</accession>
<accession>A5HJT1</accession>
<accession>B7ZLG0</accession>
<accession>B9UN80</accession>
<accession>O60827</accession>
<accession>Q14DD8</accession>
<accession>Q4ZH51</accession>
<name>FOXP3_HUMAN</name>
<protein>
<recommendedName>
<fullName>Forkhead box protein P3</fullName>
</recommendedName>
<alternativeName>
<fullName>Scurfin</fullName>
</alternativeName>
<component>
<recommendedName>
<fullName>Forkhead box protein P3, C-terminally processed</fullName>
</recommendedName>
</component>
<component>
<recommendedName>
<fullName>Forkhead box protein P3 41 kDa form</fullName>
</recommendedName>
</component>
</protein>
<gene>
<name type="primary">FOXP3</name>
<name type="synonym">IPEX</name>
<name type="ORF">JM2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2001" name="Nat. Genet." volume="27" first="68" last="73">
<title>Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse.</title>
<authorList>
<person name="Brunkow M.E."/>
<person name="Jeffery E.W."/>
<person name="Hjerrild K.A."/>
<person name="Paeper B."/>
<person name="Clark L.B."/>
<person name="Yasayko S.-A."/>
<person name="Wilkinson J.E."/>
<person name="Galas D."/>
<person name="Ziegler S.F."/>
<person name="Ramsdell F."/>
</authorList>
<dbReference type="PubMed" id="11138001"/>
<dbReference type="DOI" id="10.1038/83784"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="submission" date="2007-04" db="EMBL/GenBank/DDBJ databases">
<title>Cloning and expression of the cDNA for FOXP3.</title>
<authorList>
<person name="Wang J."/>
<person name="Liu Q."/>
<person name="Zhang Y."/>
<person name="Xu Z."/>
<person name="Huang C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="3">
<citation type="submission" date="2008-06" db="EMBL/GenBank/DDBJ databases">
<title>Functional characterization of FOXP3 splice variants in human regulatory T cells.</title>
<authorList>
<person name="Kaur G."/>
<person name="Goodall J.C."/>
<person name="Jarvis L.B."/>
<person name="Gaston J.S.H."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4)</scope>
</reference>
<reference key="4">
<citation type="submission" date="2005-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Lin L."/>
<person name="Nong W."/>
<person name="Li H."/>
<person name="Ke R."/>
<person name="Shen C."/>
<person name="Zhong G."/>
<person name="Zheng Z."/>
<person name="Liang M."/>
<person name="Huang B."/>
<person name="Zhou G."/>
<person name="Yang S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2005" name="Nature" volume="434" first="325" last="337">
<title>The DNA sequence of the human X chromosome.</title>
<authorList>
<person name="Ross M.T."/>
<person name="Grafham D.V."/>
<person name="Coffey A.J."/>
<person name="Scherer S."/>
<person name="McLay K."/>
<person name="Muzny D."/>
<person name="Platzer M."/>
<person name="Howell G.R."/>
<person name="Burrows C."/>
<person name="Bird C.P."/>
<person name="Frankish A."/>
<person name="Lovell F.L."/>
<person name="Howe K.L."/>
<person name="Ashurst J.L."/>
<person name="Fulton R.S."/>
<person name="Sudbrak R."/>
<person name="Wen G."/>
<person name="Jones M.C."/>
<person name="Hurles M.E."/>
<person name="Andrews T.D."/>
<person name="Scott C.E."/>
<person name="Searle S."/>
<person name="Ramser J."/>
<person name="Whittaker A."/>
<person name="Deadman R."/>
<person name="Carter N.P."/>
<person name="Hunt S.E."/>
<person name="Chen R."/>
<person name="Cree A."/>
<person name="Gunaratne P."/>
<person name="Havlak P."/>
<person name="Hodgson A."/>
<person name="Metzker M.L."/>
<person name="Richards S."/>
<person name="Scott G."/>
<person name="Steffen D."/>
<person name="Sodergren E."/>
<person name="Wheeler D.A."/>
<person name="Worley K.C."/>
<person name="Ainscough R."/>
<person name="Ambrose K.D."/>
<person name="Ansari-Lari M.A."/>
<person name="Aradhya S."/>
<person name="Ashwell R.I."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Ballabio A."/>
<person name="Banerjee R."/>
<person name="Barker G.E."/>
<person name="Barlow K.F."/>
<person name="Barrett I.P."/>
<person name="Bates K.N."/>
<person name="Beare D.M."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Beck A."/>
<person name="Bethel G."/>
<person name="Blechschmidt K."/>
<person name="Brady N."/>
<person name="Bray-Allen S."/>
<person name="Bridgeman A.M."/>
<person name="Brown A.J."/>
<person name="Brown M.J."/>
<person name="Bonnin D."/>
<person name="Bruford E.A."/>
<person name="Buhay C."/>
<person name="Burch P."/>
<person name="Burford D."/>
<person name="Burgess J."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Bye J.M."/>
<person name="Carder C."/>
<person name="Carrel L."/>
<person name="Chako J."/>
<person name="Chapman J.C."/>
<person name="Chavez D."/>
<person name="Chen E."/>
<person name="Chen G."/>
<person name="Chen Y."/>
<person name="Chen Z."/>
<person name="Chinault C."/>
<person name="Ciccodicola A."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Clerc-Blankenburg K."/>
<person name="Clifford K."/>
<person name="Cobley V."/>
<person name="Cole C.G."/>
<person name="Conquer J.S."/>
<person name="Corby N."/>
<person name="Connor R.E."/>
<person name="David R."/>
<person name="Davies J."/>
<person name="Davis C."/>
<person name="Davis J."/>
<person name="Delgado O."/>
<person name="Deshazo D."/>
<person name="Dhami P."/>
<person name="Ding Y."/>
<person name="Dinh H."/>
<person name="Dodsworth S."/>
<person name="Draper H."/>
<person name="Dugan-Rocha S."/>
<person name="Dunham A."/>
<person name="Dunn M."/>
<person name="Durbin K.J."/>
<person name="Dutta I."/>
<person name="Eades T."/>
<person name="Ellwood M."/>
<person name="Emery-Cohen A."/>
<person name="Errington H."/>
<person name="Evans K.L."/>
<person name="Faulkner L."/>
<person name="Francis F."/>
<person name="Frankland J."/>
<person name="Fraser A.E."/>
<person name="Galgoczy P."/>
<person name="Gilbert J."/>
<person name="Gill R."/>
<person name="Gloeckner G."/>
<person name="Gregory S.G."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Grocock R."/>
<person name="Gu Y."/>
<person name="Gwilliam R."/>
<person name="Hamilton C."/>
<person name="Hart E.A."/>
<person name="Hawes A."/>
<person name="Heath P.D."/>
<person name="Heitmann K."/>
<person name="Hennig S."/>
<person name="Hernandez J."/>
<person name="Hinzmann B."/>
<person name="Ho S."/>
<person name="Hoffs M."/>
<person name="Howden P.J."/>
<person name="Huckle E.J."/>
<person name="Hume J."/>
<person name="Hunt P.J."/>
<person name="Hunt A.R."/>
<person name="Isherwood J."/>
<person name="Jacob L."/>
<person name="Johnson D."/>
<person name="Jones S."/>
<person name="de Jong P.J."/>
<person name="Joseph S.S."/>
<person name="Keenan S."/>
<person name="Kelly S."/>
<person name="Kershaw J.K."/>
<person name="Khan Z."/>
<person name="Kioschis P."/>
<person name="Klages S."/>
<person name="Knights A.J."/>
<person name="Kosiura A."/>
<person name="Kovar-Smith C."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leversha M."/>
<person name="Lewis L."/>
<person name="Liu W."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Loulseged H."/>
<person name="Loveland J.E."/>
<person name="Lovell J.D."/>
<person name="Lozado R."/>
<person name="Lu J."/>
<person name="Lyne R."/>
<person name="Ma J."/>
<person name="Maheshwari M."/>
<person name="Matthews L.H."/>
<person name="McDowall J."/>
<person name="McLaren S."/>
<person name="McMurray A."/>
<person name="Meidl P."/>
<person name="Meitinger T."/>
<person name="Milne S."/>
<person name="Miner G."/>
<person name="Mistry S.L."/>
<person name="Morgan M."/>
<person name="Morris S."/>
<person name="Mueller I."/>
<person name="Mullikin J.C."/>
<person name="Nguyen N."/>
<person name="Nordsiek G."/>
<person name="Nyakatura G."/>
<person name="O'dell C.N."/>
<person name="Okwuonu G."/>
<person name="Palmer S."/>
<person name="Pandian R."/>
<person name="Parker D."/>
<person name="Parrish J."/>
<person name="Pasternak S."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Pearson D.M."/>
<person name="Pelan S.E."/>
<person name="Perez L."/>
<person name="Porter K.M."/>
<person name="Ramsey Y."/>
<person name="Reichwald K."/>
<person name="Rhodes S."/>
<person name="Ridler K.A."/>
<person name="Schlessinger D."/>
<person name="Schueler M.G."/>
<person name="Sehra H.K."/>
<person name="Shaw-Smith C."/>
<person name="Shen H."/>
<person name="Sheridan E.M."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M.L."/>
<person name="Sotheran E.C."/>
<person name="Steingruber H.E."/>
<person name="Steward C.A."/>
<person name="Storey R."/>
<person name="Swann R.M."/>
<person name="Swarbreck D."/>
<person name="Tabor P.E."/>
<person name="Taudien S."/>
<person name="Taylor T."/>
<person name="Teague B."/>
<person name="Thomas K."/>
<person name="Thorpe A."/>
<person name="Timms K."/>
<person name="Tracey A."/>
<person name="Trevanion S."/>
<person name="Tromans A.C."/>
<person name="d'Urso M."/>
<person name="Verduzco D."/>
<person name="Villasana D."/>
<person name="Waldron L."/>
<person name="Wall M."/>
<person name="Wang Q."/>
<person name="Warren J."/>
<person name="Warry G.L."/>
<person name="Wei X."/>
<person name="West A."/>
<person name="Whitehead S.L."/>
<person name="Whiteley M.N."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams G."/>
<person name="Williams L."/>
<person name="Williamson A."/>
<person name="Williamson H."/>
<person name="Wilming L."/>
<person name="Woodmansey R.L."/>
<person name="Wray P.W."/>
<person name="Yen J."/>
<person name="Zhang J."/>
<person name="Zhou J."/>
<person name="Zoghbi H."/>
<person name="Zorilla S."/>
<person name="Buck D."/>
<person name="Reinhardt R."/>
<person name="Poustka A."/>
<person name="Rosenthal A."/>
<person name="Lehrach H."/>
<person name="Meindl A."/>
<person name="Minx P.J."/>
<person name="Hillier L.W."/>
<person name="Willard H.F."/>
<person name="Wilson R.K."/>
<person name="Waterston R.H."/>
<person name="Rice C.M."/>
<person name="Vaudin M."/>
<person name="Coulson A."/>
<person name="Nelson D.L."/>
<person name="Weinstock G."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Gibbs R.A."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="15772651"/>
<dbReference type="DOI" id="10.1038/nature03440"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
</reference>
<reference key="7">
<citation type="submission" date="1998-04" db="EMBL/GenBank/DDBJ databases">
<title>Transcription map in Xp11.23.</title>
<authorList>
<person name="Strom T.M."/>
<person name="Nyakatura G."/>
<person name="Hellebrand H."/>
<person name="Drescher B."/>
<person name="Rosenthal A."/>
<person name="Meindl A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 16-431 (ISOFORM 3)</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="5138" last="5143">
<title>Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells.</title>
<authorList>
<person name="Bettelli E."/>
<person name="Dastrange M."/>
<person name="Oukka M."/>
</authorList>
<dbReference type="PubMed" id="15790681"/>
<dbReference type="DOI" id="10.1073/pnas.0501675102"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RELA AND NFATC2</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2007" name="Nature" volume="446" first="685" last="689">
<title>Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1.</title>
<authorList>
<person name="Ono M."/>
<person name="Yaguchi H."/>
<person name="Ohkura N."/>
<person name="Kitabayashi I."/>
<person name="Nagamura Y."/>
<person name="Nomura T."/>
<person name="Miyachi Y."/>
<person name="Tsukada T."/>
<person name="Sakaguchi S."/>
</authorList>
<dbReference type="PubMed" id="17377532"/>
<dbReference type="DOI" id="10.1038/nature05673"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RUNX1</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="4571" last="4576">
<title>FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression.</title>
<authorList>
<person name="Li B."/>
<person name="Samanta A."/>
<person name="Song X."/>
<person name="Iacono K.T."/>
<person name="Bembas K."/>
<person name="Tao R."/>
<person name="Basu S."/>
<person name="Riley J.L."/>
<person name="Hancock W.W."/>
<person name="Shen Y."/>
<person name="Saouaf S.J."/>
<person name="Greene M.I."/>
</authorList>
<dbReference type="PubMed" id="17360565"/>
<dbReference type="DOI" id="10.1073/pnas.0700298104"/>
</citation>
<scope>FUNCTION</scope>
<scope>ACETYLATION</scope>
<scope>INTERACTION WITH KAT5; HDAC7 AND HDAC9</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2008" name="J. Immunol." volume="180" first="4785" last="4792">
<title>Isoform-specific inhibition of ROR alpha-mediated transcriptional activation by human FOXP3.</title>
<authorList>
<person name="Du J."/>
<person name="Huang C."/>
<person name="Zhou B."/>
<person name="Ziegler S.F."/>
</authorList>
<dbReference type="PubMed" id="18354202"/>
<dbReference type="DOI" id="10.4049/jimmunol.180.7.4785"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RORA</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF 95-LEU-LEU-96</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2008" name="Nature" volume="453" first="236" last="240">
<title>TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function.</title>
<authorList>
<person name="Zhou L."/>
<person name="Lopes J.E."/>
<person name="Chong M.M."/>
<person name="Ivanov I.I."/>
<person name="Min R."/>
<person name="Victora G.D."/>
<person name="Shen Y."/>
<person name="Du J."/>
<person name="Rubtsov Y.P."/>
<person name="Rudensky A.Y."/>
<person name="Ziegler S.F."/>
<person name="Littman D.R."/>
</authorList>
<dbReference type="PubMed" id="18368049"/>
<dbReference type="DOI" id="10.1038/nature06878"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RORC</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="5709" last="5716">
<title>Foxp3 processing by proprotein convertases and control of regulatory T cell function.</title>
<authorList>
<person name="de Zoeten E.F."/>
<person name="Lee I."/>
<person name="Wang L."/>
<person name="Chen C."/>
<person name="Ge G."/>
<person name="Wells A.D."/>
<person name="Hancock W.W."/>
<person name="Ozkaynak E."/>
</authorList>
<dbReference type="PubMed" id="19117830"/>
<dbReference type="DOI" id="10.1074/jbc.m807322200"/>
</citation>
<scope>PROTEOLYTIC PROCESSING</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2010" name="Nat. Immunol." volume="11" first="846" last="853">
<title>Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells.</title>
<authorList>
<person name="Gandhi R."/>
<person name="Kumar D."/>
<person name="Burns E.J."/>
<person name="Nadeau M."/>
<person name="Dake B."/>
<person name="Laroni A."/>
<person name="Kozoriz D."/>
<person name="Weiner H.L."/>
<person name="Quintana F.J."/>
</authorList>
<dbReference type="PubMed" id="20676092"/>
<dbReference type="DOI" id="10.1038/ni.1915"/>
</citation>
<scope>INTERACTION WITH IKZF3</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2012" name="Eur. J. Immunol." volume="42" first="1627" last="1638">
<title>Subcellular localization of FOXP3 in human regulatory and nonregulatory T cells.</title>
<authorList>
<person name="Magg T."/>
<person name="Mannert J."/>
<person name="Ellwart J.W."/>
<person name="Schmid I."/>
<person name="Albert M.H."/>
</authorList>
<dbReference type="PubMed" id="22678915"/>
<dbReference type="DOI" id="10.1002/eji.201141838"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>NUCLEAR LOCALIZATION SIGNAL</scope>
<scope>NUCLEAR EXPORT SIGNAL</scope>
<scope>MUTAGENESIS OF LEU-69; LEU-71; LEU-74; LEU-76; 415-LYS-LYS-416; LEU-242; LEU-246 AND LEU-248</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2012" name="J. Immunol." volume="188" first="2712" last="2721">
<title>Three novel acetylation sites in the Foxp3 transcription factor regulate the suppressive activity of regulatory T cells.</title>
<authorList>
<person name="Kwon H.S."/>
<person name="Lim H.W."/>
<person name="Wu J."/>
<person name="Schnolzer M."/>
<person name="Verdin E."/>
<person name="Ott M."/>
</authorList>
<dbReference type="PubMed" id="22312127"/>
<dbReference type="DOI" id="10.4049/jimmunol.1100903"/>
</citation>
<scope>ACETYLATION AT LYS-31; LYS-263 AND LYS-268</scope>
<scope>DEACETYLATION BY SIRT1</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2013" name="Blood" volume="121" first="1265" last="1275">
<title>A novel function for FOXP3 in humans: intrinsic regulation of conventional T cells.</title>
<authorList>
<person name="McMurchy A.N."/>
<person name="Gillies J."/>
<person name="Gizzi M.C."/>
<person name="Riba M."/>
<person name="Garcia-Manteiga J.M."/>
<person name="Cittaro D."/>
<person name="Lazarevic D."/>
<person name="Di Nunzio S."/>
<person name="Piras I.S."/>
<person name="Bulfone A."/>
<person name="Roncarolo M.G."/>
<person name="Stupka E."/>
<person name="Bacchetta R."/>
<person name="Levings M.K."/>
</authorList>
<dbReference type="PubMed" id="23169781"/>
<dbReference type="DOI" id="10.1182/blood-2012-05-431023"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2013" name="Front. Oncol." volume="3" first="294" last="294">
<title>Searching for the Achilles Heel of FOXP3.</title>
<authorList>
<person name="Lozano T."/>
<person name="Casares N."/>
<person name="Lasarte J.J."/>
</authorList>
<dbReference type="PubMed" id="24350059"/>
<dbReference type="DOI" id="10.3389/fonc.2013.00294"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2013" name="Immunity" volume="39" first="259" last="271">
<title>Stabilization of the transcription factor Foxp3 by the deubiquitinase USP7 increases Treg-cell-suppressive capacity.</title>
<authorList>
<person name="van Loosdregt J."/>
<person name="Fleskens V."/>
<person name="Fu J."/>
<person name="Brenkman A.B."/>
<person name="Bekker C.P."/>
<person name="Pals C.E."/>
<person name="Meerding J."/>
<person name="Berkers C.R."/>
<person name="Barbi J."/>
<person name="Grone A."/>
<person name="Sijts A.J."/>
<person name="Maurice M.M."/>
<person name="Kalkhoven E."/>
<person name="Prakken B.J."/>
<person name="Ovaa H."/>
<person name="Pan F."/>
<person name="Zaiss D.M."/>
<person name="Coffer P.J."/>
</authorList>
<dbReference type="PubMed" id="23973222"/>
<dbReference type="DOI" id="10.1016/j.immuni.2013.05.018"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>DEUBIQUITINATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH USP7</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2013" name="Immunity" volume="39" first="272" last="285">
<title>The ubiquitin ligase Stub1 negatively modulates regulatory T cell suppressive activity by promoting degradation of the transcription factor Foxp3.</title>
<authorList>
<person name="Chen Z."/>
<person name="Barbi J."/>
<person name="Bu S."/>
<person name="Yang H.Y."/>
<person name="Li Z."/>
<person name="Gao Y."/>
<person name="Jinasena D."/>
<person name="Fu J."/>
<person name="Lin F."/>
<person name="Chen C."/>
<person name="Zhang J."/>
<person name="Yu N."/>
<person name="Li X."/>
<person name="Shan Z."/>
<person name="Nie J."/>
<person name="Gao Z."/>
<person name="Tian H."/>
<person name="Li Y."/>
<person name="Yao Z."/>
<person name="Zheng Y."/>
<person name="Park B.V."/>
<person name="Pan Z."/>
<person name="Zhang J."/>
<person name="Dang E."/>
<person name="Li Z."/>
<person name="Wang H."/>
<person name="Luo W."/>
<person name="Li L."/>
<person name="Semenza G.L."/>
<person name="Zheng S.G."/>
<person name="Loser K."/>
<person name="Tsun A."/>
<person name="Greene M.I."/>
<person name="Pardoll D.M."/>
<person name="Pan F."/>
<person name="Li B."/>
</authorList>
<dbReference type="PubMed" id="23973223"/>
<dbReference type="DOI" id="10.1016/j.immuni.2013.08.006"/>
</citation>
<scope>INTERACTION WITH STUB1; HSPA8 AND HSPA1A/B</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>UBIQUITINATION</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2013" name="J. Immunol." volume="190" first="4470" last="4473">
<title>Cutting Edge: a novel, human-specific interacting protein couples FOXP3 to a chromatin-remodeling complex that contains KAP1/TRIM28.</title>
<authorList>
<person name="Huang C."/>
<person name="Martin S."/>
<person name="Pfleger C."/>
<person name="Du J."/>
<person name="Buckner J.H."/>
<person name="Bluestone J.A."/>
<person name="Riley J.L."/>
<person name="Ziegler S.F."/>
</authorList>
<dbReference type="PubMed" id="23543754"/>
<dbReference type="DOI" id="10.4049/jimmunol.1203561"/>
</citation>
<scope>INTERACTION WITH ZFP90</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2013" name="Nat. Med." volume="19" first="322" last="328">
<title>Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-alpha in rheumatoid arthritis.</title>
<authorList>
<person name="Nie H."/>
<person name="Zheng Y."/>
<person name="Li R."/>
<person name="Guo T.B."/>
<person name="He D."/>
<person name="Fang L."/>
<person name="Liu X."/>
<person name="Xiao L."/>
<person name="Chen X."/>
<person name="Wan B."/>
<person name="Chin Y.E."/>
<person name="Zhang J.Z."/>
</authorList>
<dbReference type="PubMed" id="23396208"/>
<dbReference type="DOI" id="10.1038/nm.3085"/>
</citation>
<scope>PHOSPHORYLATION AT SER-418</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH PPP1CA; PPP1CB AND PPP1CG</scope>
<scope>MUTAGENESIS OF SER-418 AND SER-422</scope>
<scope>DEPHOSPHORYLATION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2014" name="Int. Rev. Immunol." volume="33" first="110" last="128">
<title>The role of FOXP3 in regulating immune responses.</title>
<authorList>
<person name="Vent-Schmidt J."/>
<person name="Han J.M."/>
<person name="MacDonald K.G."/>
<person name="Levings M.K."/>
</authorList>
<dbReference type="PubMed" id="23947341"/>
<dbReference type="DOI" id="10.3109/08830185.2013.811657"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2014" name="Int. Rev. Immunol." volume="33" first="129" last="145">
<title>Forkhead box P3: the peacekeeper of the immune system.</title>
<authorList>
<person name="Passerini L."/>
<person name="Santoni de Sio F.R."/>
<person name="Roncarolo M.G."/>
<person name="Bacchetta R."/>
</authorList>
<dbReference type="PubMed" id="24354325"/>
<dbReference type="DOI" id="10.3109/08830185.2013.863303"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2014" name="Nat. Rev. Immunol." volume="14" first="343" last="349">
<title>FOXP3 and scurfy: how it all began.</title>
<authorList>
<person name="Ramsdell F."/>
<person name="Ziegler S.F."/>
</authorList>
<dbReference type="PubMed" id="24722479"/>
<dbReference type="DOI" id="10.1038/nri3650"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2014" name="Trends Immunol." volume="35" first="368" last="378">
<title>Post-translational modification networks regulating FOXP3 function.</title>
<authorList>
<person name="van Loosdregt J."/>
<person name="Coffer P.J."/>
</authorList>
<dbReference type="PubMed" id="25047417"/>
<dbReference type="DOI" id="10.1016/j.it.2014.06.005"/>
</citation>
<scope>REVIEW ON PTM</scope>
</reference>
<reference key="27" evidence="1">
<citation type="journal article" date="2011" name="Immunity" volume="34" first="479" last="491">
<title>Structure of a domain-swapped FOXP3 dimer on DNA and its function in regulatory T cells.</title>
<authorList>
<person name="Bandukwala H.S."/>
<person name="Wu Y."/>
<person name="Feuerer M."/>
<person name="Chen Y."/>
<person name="Barboza B."/>
<person name="Ghosh S."/>
<person name="Stroud J.C."/>
<person name="Benoist C."/>
<person name="Mathis D."/>
<person name="Rao A."/>
<person name="Chen L."/>
</authorList>
<dbReference type="PubMed" id="21458306"/>
<dbReference type="DOI" id="10.1016/j.immuni.2011.02.017"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) OF 336-417 IN COMPLEX WITH DNA AND NFATC2</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>DOMAIN FORK-HEAD</scope>
<scope>INTERACTION WITH NFATC2</scope>
<scope>CHARACTERIZATION OF VARIANTS IPEX GLU-251 DEL; HIS-347; CYS-371 AND ALA-373</scope>
<scope>MUTAGENESIS OF TRP-348; MET-370 AND ALA-372</scope>
</reference>
<reference key="28" evidence="2">
<citation type="journal article" date="2015" name="Nucleic Acids Res." volume="43" first="1268" last="1282">
<title>DNA binding by FOXP3 domain-swapped dimer suggests mechanisms of long-range chromosomal interactions.</title>
<authorList>
<person name="Chen Y."/>
<person name="Chen C."/>
<person name="Zhang Z."/>
<person name="Liu C.C."/>
<person name="Johnson M.E."/>
<person name="Espinoza C.A."/>
<person name="Edsall L.E."/>
<person name="Ren B."/>
<person name="Zhou X.J."/>
<person name="Grant S.F."/>
<person name="Wells A.D."/>
<person name="Chen L."/>
</authorList>
<dbReference type="PubMed" id="25567984"/>
<dbReference type="DOI" id="10.1093/nar/gku1373"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.40 ANGSTROMS) OF 336-417 IN COMPLEX WITH DNA</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2000" name="J. Clin. Invest." volume="106" first="R75" last="R81">
<title>JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome.</title>
<authorList>
<person name="Chatila T.A."/>
<person name="Blaeser F."/>
<person name="Ho N."/>
<person name="Lederman H.M."/>
<person name="Voulgaropoulos C."/>
<person name="Helms C."/>
<person name="Bowcock A.M."/>
</authorList>
<dbReference type="PubMed" id="11120765"/>
<dbReference type="DOI" id="10.1172/jci11679"/>
</citation>
<scope>VARIANT IPEX GLU-251 DEL</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2001" name="J. Med. Genet." volume="38" first="874" last="876">
<title>Novel mutations of FOXP3 in two Japanese patients with immune dysregulation, polyendocrinopathy, enteropathy, X linked syndrome (IPEX).</title>
<authorList>
<person name="Kobayashi I."/>
<person name="Shiari R."/>
<person name="Yamada M."/>
<person name="Kawamura N."/>
<person name="Okano M."/>
<person name="Yara A."/>
<person name="Iguchi A."/>
<person name="Ishikawa N."/>
<person name="Ariga T."/>
<person name="Sakiyama Y."/>
<person name="Ochs H.D."/>
<person name="Kobayashi K."/>
</authorList>
<dbReference type="PubMed" id="11768393"/>
<dbReference type="DOI" id="10.1136/jmg.38.12.874"/>
</citation>
<scope>VARIANT IPEX VAL-363</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2001" name="Nat. Genet." volume="27" first="18" last="20">
<title>X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy.</title>
<authorList>
<person name="Wildin R.S."/>
<person name="Ramsdell F."/>
<person name="Peake J."/>
<person name="Faravelli F."/>
<person name="Casanova J.-L."/>
<person name="Buist N."/>
<person name="Levy-Lahad E."/>
<person name="Mazzella M."/>
<person name="Goulet O."/>
<person name="Perroni L."/>
<person name="Bricarelli F.D."/>
<person name="Byrne G."/>
<person name="McEuen M."/>
<person name="Proll S."/>
<person name="Appleby M."/>
<person name="Brunkow M.E."/>
</authorList>
<dbReference type="PubMed" id="11137992"/>
<dbReference type="DOI" id="10.1038/83707"/>
</citation>
<scope>VARIANTS IPEX CYS-371; THR-384 AND TRP-397</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2001" name="Nat. Genet." volume="27" first="20" last="21">
<title>The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.</title>
<authorList>
<person name="Bennett C.L."/>
<person name="Christie J."/>
<person name="Ramsdell F."/>
<person name="Brunkow M.E."/>
<person name="Ferguson P.J."/>
<person name="Whitesell L."/>
<person name="Kelly T.E."/>
<person name="Saulsbury F.T."/>
<person name="Chance P.F."/>
<person name="Ochs H.D."/>
</authorList>
<dbReference type="PubMed" id="11137993"/>
<dbReference type="DOI" id="10.1038/83713"/>
</citation>
<scope>VARIANT IPEX THR-384</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2008" name="J. Allergy Clin. Immunol." volume="122" first="1105" last="1112">
<title>Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity.</title>
<authorList>
<person name="Gambineri E."/>
<person name="Perroni L."/>
<person name="Passerini L."/>
<person name="Bianchi L."/>
<person name="Doglioni C."/>
<person name="Meschi F."/>
<person name="Bonfanti R."/>
<person name="Sznajer Y."/>
<person name="Tommasini A."/>
<person name="Lawitschka A."/>
<person name="Junker A."/>
<person name="Dunstheimer D."/>
<person name="Heidemann P.H."/>
<person name="Cazzola G."/>
<person name="Cipolli M."/>
<person name="Friedrich W."/>
<person name="Janic D."/>
<person name="Azzi N."/>
<person name="Richmond E."/>
<person name="Vignola S."/>
<person name="Barabino A."/>
<person name="Chiumello G."/>
<person name="Azzari C."/>
<person name="Roncarolo M.G."/>
<person name="Bacchetta R."/>
</authorList>
<dbReference type="PubMed" id="18951619"/>
<dbReference type="DOI" id="10.1016/j.jaci.2008.09.027"/>
</citation>
<scope>VARIANTS IPEX PRO-242; LEU-324; ALA-339; HIS-347; ALA-373; CYS-374 AND THR-384</scope>
<scope>CHARACTERIZATION OF VARIANTS IPEX PRO-242; LEU-324; ALA-339; HIS-347; ALA-373; CYS-374 AND THR-384</scope>
</reference>
<comment type="function">
<text evidence="3 9 10 11 12 13 17 20">Transcriptional regulator which is crucial for the development and inhibitory function of regulatory T-cells (Treg). Plays an essential role in maintaining homeostasis of the immune system by allowing the acquisition of full suppressive function and stability of the Treg lineage, and by directly modulating the expansion and function of conventional T-cells. Can act either as a transcriptional repressor or a transcriptional activator depending on its interactions with other transcription factors, histone acetylases and deacetylases. The suppressive activity of Treg involves the coordinate activation of many genes, including CTLA4 and TNFRSF18 by FOXP3 along with repression of genes encoding cytokines such as interleukin-2 (IL2) and interferon-gamma (IFNG). Inhibits cytokine production and T-cell effector function by repressing the activity of two key transcription factors, RELA and NFATC2 (PubMed:15790681). Mediates transcriptional repression of IL2 via its association with histone acetylase KAT5 and histone deacetylase HDAC7 (PubMed:17360565). Can activate the expression of TNFRSF18, IL2RA and CTLA4 and repress the expression of IL2 and IFNG via its association with transcription factor RUNX1 (PubMed:17377532). Inhibits the differentiation of IL17 producing helper T-cells (Th17) by antagonizing RORC function, leading to down-regulation of IL17 expression, favoring Treg development (PubMed:18368049). Inhibits the transcriptional activator activity of RORA (PubMed:18354202). Can repress the expression of IL2 and IFNG via its association with transcription factor IKZF4 (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="3 9 10 11 12 13 16 17 21 22 23 24 25">Homodimer (PubMed:21458306, PubMed:25567984). Dimerization is essential for its transcriptional regulator activity (PubMed:21458306). Interacts with IKZF3. Isoform 1 (via LXXLL motif), but not isoform 2, interacts with isoform 4 of RORA (via AF-2 motif). Interacts with STUB1, HSPA8 and HSPA1A/B. Interacts with PPP1CA, PPP1CB and PPP1CG. Interacts with KAT5 and HDAC7. Interacts with HDAC9 in the absence of T-cell stimulation. Interacts with USP7. Interacts with isoform 2 of ZFP90 and can form a complex with TRIM28 in the presence of isoform 2 of ZFP90. Interacts with RUNX1. Interacts with RORC. Interacts with RELA and NFATC2. Interacts with RUNX2, RUNX3 and IKZF4 (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-983719">
<id>Q9BZS1</id>
</interactant>
<interactant intactId="EBI-2806743">
<id>P53539</id>
<label>FOSB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-983719">
<id>Q9BZS1</id>
</interactant>
<interactant intactId="EBI-747204">
<id>Q9UKT9</id>
<label>IKZF3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-983719">
<id>Q9BZS1</id>
</interactant>
<interactant intactId="EBI-3957694">
<id>Q9BYR6</id>
<label>KRTAP3-3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-983719">
<id>Q9BZS1</id>
</interactant>
<interactant intactId="EBI-11962084">
<id>Q3LI66</id>
<label>KRTAP6-2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-983719">
<id>Q9BZS1</id>
</interactant>
<interactant intactId="EBI-10261141">
<id>Q8IUC2</id>
<label>KRTAP8-1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-983719">
<id>Q9BZS1</id>
</interactant>
<interactant intactId="EBI-357253">
<id>P62136</id>
<label>PPP1CA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-983719">
<id>Q9BZS1</id>
</interactant>
<interactant intactId="EBI-10172814">
<id>P86479</id>
<label>PRR20C</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-983719">
<id>Q9BZS1</id>
</interactant>
<interactant intactId="EBI-12754095">
<id>P86480</id>
<label>PRR20D</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-983719">
<id>Q9BZS1</id>
</interactant>
<interactant intactId="EBI-12700196">
<id>P86478</id>
<label>PRR20E</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-983719">
<id>Q9BZS1</id>
</interactant>
<interactant intactId="EBI-740322">
<id>Q93062</id>
<label>RBPMS</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-983719">
<id>Q9BZS1</id>
</interactant>
<interactant intactId="EBI-740343">
<id>Q93062-3</id>
<label>RBPMS</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-983719">
<id>Q9BZS1</id>
</interactant>
<interactant intactId="EBI-11295807">
<id>P35398-4</id>
<label>RORA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-983719">
<id>Q9BZS1</id>
</interactant>
<interactant intactId="EBI-357085">
<id>Q9UNE7</id>
<label>STUB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-983719">
<id>Q9BZS1</id>
</interactant>
<interactant intactId="EBI-11419904">
<id>Q8TF47-3</id>
<label>ZFP90</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-983719">
<id>Q9BZS1</id>
</interactant>
<interactant intactId="EBI-11820565">
<id>P08107</id>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9695448">
<id>Q9BZS1-1</id>
</interactant>
<interactant intactId="EBI-1048378">
<id>Q8WUI4</id>
<label>HDAC7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9695448">
<id>Q9BZS1-1</id>
</interactant>
<interactant intactId="EBI-399080">
<id>Q92993</id>
<label>KAT5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9695448">
<id>Q9BZS1-1</id>
</interactant>
<interactant intactId="EBI-1018629">
<id>P11309-1</id>
<label>PIM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-16338471">
<id>Q9BZS1-2</id>
</interactant>
<interactant intactId="EBI-1048378">
<id>Q8WUI4</id>
<label>HDAC7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="4 10 12 19 21 23 24">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="19">Cytoplasm</location>
</subcellularLocation>
<text evidence="3 19">Predominantly expressed in the cytoplasm in activated conventional T-cells whereas predominantly expressed in the nucleus in regulatory T-cells (Treg). The 41 kDa form derived by proteolytic processing is found exclusively in the chromatin fraction of activated Treg cells (By similarity).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9BZS1-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9BZS1-2</id>
<name>2</name>
<sequence type="described" ref="VSP_015796"/>
</isoform>
<isoform>
<id>Q9BZS1-3</id>
<name>3</name>
<sequence type="described" ref="VSP_015796 VSP_036418"/>
</isoform>
<isoform>
<id>Q9BZS1-4</id>
<name>4</name>
<sequence type="described" ref="VSP_047859"/>
</isoform>
</comment>
<comment type="induction">
<text evidence="24">Down-regulated in regulatory T-cells (Treg) during inflammation.</text>
</comment>
<comment type="domain">
<text evidence="17">The fork-head DNA-binding domain is essential for its dimerization and interaction with NFATC2.</text>
</comment>
<comment type="PTM">
<text evidence="23 24">Polyubiquitinated, leading to its proteasomal degradation in regulatory T-cells (Treg) which is mediated by STUB1 in a HSPA1A/B-dependent manner. Deubiquitinated by USP7 leading to increase in protein stability.</text>
</comment>
<comment type="PTM">
<text evidence="3 21">Phosphorylation at Ser-418 regulates its transcriptional repressor activity and consequently, regulatory T-cells (Treg) suppressive function. Dephosphorylated at Ser-418 by protein phosphatase 1 (PP1) in Treg cells derived from patients with rheumatoid arthritis. Phosphorylation by CDK2 negatively regulates its transcriptional activity and protein stability (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="10 18">Acetylation on lysine residues stabilizes FOXP3 and promotes differentiation of T-cells into induced regulatory T-cells (iTregs) associated with suppressive functions. Deacetylated by SIRT1.</text>
</comment>
<comment type="PTM">
<text evidence="15">Undergoes proteolytic cleavage in activated regulatory T-cells (Treg), and can be cleaved at either the N- or C-terminal site, or at both sites.</text>
</comment>
<comment type="disease" evidence="5 6 7 8 14 17">
<disease id="DI-01811">
<name>Immunodeficiency polyendocrinopathy, enteropathy, X-linked syndrome</name>
<acronym>IPEX</acronym>
<description>Characterized by neonatal onset insulin-dependent diabetes mellitus, infections, secretory diarrhea, thrombocytopenia, anemia and eczema. It is usually lethal in infancy.</description>
<dbReference type="MIM" id="304790"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/FOXP3ID44129chXp11.html"/>
</comment>
<comment type="online information" name="FOXP3base">
<link uri="http://structure.bmc.lu.se/idbase/FOXP3base/"/>
<text>FOXP3 mutation db</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/FOXP3"/>
<text>FOXP3 entry</text>
</comment>
<dbReference type="EMBL" id="AF277993">
<property type="protein sequence ID" value="AAG53607.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EF534714">
<property type="protein sequence ID" value="ABQ15210.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EU855812">
<property type="protein sequence ID" value="ACJ46653.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ010327">
<property type="protein sequence ID" value="AAY27088.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF235097">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC113401">
<property type="protein sequence ID" value="AAI13402.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC113403">
<property type="protein sequence ID" value="AAI13404.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC143785">
<property type="protein sequence ID" value="AAI43786.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ005891">
<property type="protein sequence ID" value="CAA06748.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS14323.1">
<molecule id="Q9BZS1-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS48109.1">
<molecule id="Q9BZS1-2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001107849.1">
<molecule id="Q9BZS1-2"/>
<property type="nucleotide sequence ID" value="NM_001114377.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_054728.2">
<molecule id="Q9BZS1-1"/>
<property type="nucleotide sequence ID" value="NM_014009.3"/>
</dbReference>
<dbReference type="PDB" id="3QRF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="F/G/H/I=336-417"/>
</dbReference>
<dbReference type="PDB" id="4WK8">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.40"/>
<property type="chains" value="F/G=336-417"/>
</dbReference>
<dbReference type="PDBsum" id="3QRF"/>
<dbReference type="PDBsum" id="4WK8"/>
<dbReference type="SMR" id="Q9BZS1"/>
<dbReference type="BioGRID" id="119170">
<property type="interactions" value="80"/>
</dbReference>
<dbReference type="CORUM" id="Q9BZS1"/>
<dbReference type="DIP" id="DIP-36584N"/>
<dbReference type="IntAct" id="Q9BZS1">
<property type="interactions" value="71"/>
</dbReference>
<dbReference type="MINT" id="Q9BZS1"/>
<dbReference type="STRING" id="9606.ENSP00000365380"/>
<dbReference type="iPTMnet" id="Q9BZS1"/>
<dbReference type="PhosphoSitePlus" id="Q9BZS1"/>
<dbReference type="SwissPalm" id="Q9BZS1"/>
<dbReference type="BioMuta" id="FOXP3"/>
<dbReference type="DMDM" id="14548061"/>
<dbReference type="MassIVE" id="Q9BZS1"/>
<dbReference type="MaxQB" id="Q9BZS1"/>
<dbReference type="PaxDb" id="Q9BZS1"/>
<dbReference type="PeptideAtlas" id="Q9BZS1"/>
<dbReference type="PRIDE" id="Q9BZS1"/>
<dbReference type="ProteomicsDB" id="7545"/>
<dbReference type="ProteomicsDB" id="79899">
<molecule id="Q9BZS1-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="79900">
<molecule id="Q9BZS1-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="79901">
<molecule id="Q9BZS1-3"/>
</dbReference>
<dbReference type="TopDownProteomics" id="Q9BZS1-3">
<molecule id="Q9BZS1-3"/>
</dbReference>
<dbReference type="Antibodypedia" id="485">
<property type="antibodies" value="1867 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="50943"/>
<dbReference type="Ensembl" id="ENST00000376199">
<molecule id="Q9BZS1-2"/>
<property type="protein sequence ID" value="ENSP00000365372"/>
<property type="gene ID" value="ENSG00000049768"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000376207">
<molecule id="Q9BZS1-1"/>
<property type="protein sequence ID" value="ENSP00000365380"/>
<property type="gene ID" value="ENSG00000049768"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000518685">
<molecule id="Q9BZS1-4"/>
<property type="protein sequence ID" value="ENSP00000428952"/>
<property type="gene ID" value="ENSG00000049768"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000557224">
<molecule id="Q9BZS1-3"/>
<property type="protein sequence ID" value="ENSP00000451208"/>
<property type="gene ID" value="ENSG00000049768"/>
</dbReference>
<dbReference type="GeneID" id="50943"/>
<dbReference type="KEGG" id="hsa:50943"/>
<dbReference type="UCSC" id="uc004dne.5">
<molecule id="Q9BZS1-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="50943"/>
<dbReference type="DisGeNET" id="50943"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000049768.14"/>
<dbReference type="GeneCards" id="FOXP3"/>
<dbReference type="GeneReviews" id="FOXP3"/>
<dbReference type="HGNC" id="HGNC:6106">
<property type="gene designation" value="FOXP3"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000049768">
<property type="expression patterns" value="Tissue enhanced (blood, lymphoid tissue)"/>
</dbReference>
<dbReference type="MalaCards" id="FOXP3"/>
<dbReference type="MIM" id="300292">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="304790">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9BZS1"/>
<dbReference type="OpenTargets" id="ENSG00000049768"/>
<dbReference type="Orphanet" id="37042">
<property type="disease" value="Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA201094"/>
<dbReference type="eggNOG" id="KOG4385">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000161807"/>
<dbReference type="InParanoid" id="Q9BZS1"/>
<dbReference type="KO" id="K10163"/>
<dbReference type="OMA" id="FAYFRNH"/>
<dbReference type="OrthoDB" id="836427at2759"/>
<dbReference type="PhylomeDB" id="Q9BZS1"/>
<dbReference type="TreeFam" id="TF326978"/>
<dbReference type="PathwayCommons" id="Q9BZS1"/>
<dbReference type="Reactome" id="R-HSA-8877330">
<property type="pathway name" value="RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8939256">
<property type="pathway name" value="RUNX1 regulates transcription of genes involved in WNT signaling"/>
</dbReference>
<dbReference type="SignaLink" id="Q9BZS1"/>
<dbReference type="SIGNOR" id="Q9BZS1"/>
<dbReference type="BioGRID-ORCS" id="50943">
<property type="hits" value="2 hits in 523 CRISPR screens"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q9BZS1"/>
<dbReference type="GeneWiki" id="FOXP3"/>
<dbReference type="GenomeRNAi" id="50943"/>
<dbReference type="Pharos" id="Q9BZS1">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q9BZS1"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome X"/>
</dbReference>
<dbReference type="RNAct" id="Q9BZS1">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000049768">
<property type="expression patterns" value="Expressed in amniotic fluid and 134 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q9BZS1">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9BZS1">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0035035">
<property type="term" value="F:histone acetyltransferase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042826">
<property type="term" value="F:histone deacetylase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0051059">
<property type="term" value="F:NF-kappaB binding"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051525">
<property type="term" value="F:NFAT protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043565">
<property type="term" value="F:sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990837">
<property type="term" value="F:sequence-specific double-stranded DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003714">
<property type="term" value="F:transcription corepressor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001782">
<property type="term" value="P:B cell homeostasis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002362">
<property type="term" value="P:CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006338">
<property type="term" value="P:chromatin remodeling"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001816">
<property type="term" value="P:cytokine production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002262">
<property type="term" value="P:myeloid cell homeostasis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046007">
<property type="term" value="P:negative regulation of activated T cell proliferation"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002677">
<property type="term" value="P:negative regulation of chronic inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032792">
<property type="term" value="P:negative regulation of CREB transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042036">
<property type="term" value="P:negative regulation of cytokine biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050710">
<property type="term" value="P:negative regulation of cytokine secretion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043433">
<property type="term" value="P:negative regulation of DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035067">
<property type="term" value="P:negative regulation of histone acetylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031064">
<property type="term" value="P:negative regulation of histone deacetylation"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050777">
<property type="term" value="P:negative regulation of immune response"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032689">
<property type="term" value="P:negative regulation of interferon-gamma production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032693">
<property type="term" value="P:negative regulation of interleukin-10 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032700">
<property type="term" value="P:negative regulation of interleukin-17 production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032703">
<property type="term" value="P:negative regulation of interleukin-2 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032713">
<property type="term" value="P:negative regulation of interleukin-4 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032714">
<property type="term" value="P:negative regulation of interleukin-5 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032715">
<property type="term" value="P:negative regulation of interleukin-6 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048294">
<property type="term" value="P:negative regulation of isotype switching to IgE isotypes"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032088">
<property type="term" value="P:negative regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002725">
<property type="term" value="P:negative regulation of T cell cytokine production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042130">
<property type="term" value="P:negative regulation of T cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000320">
<property type="term" value="P:negative regulation of T-helper 17 cell differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032720">
<property type="term" value="P:negative regulation of tumor necrosis factor production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032831">
<property type="term" value="P:positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035066">
<property type="term" value="P:positive regulation of histone acetylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0033092">
<property type="term" value="P:positive regulation of immature T cell proliferation in thymus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032753">
<property type="term" value="P:positive regulation of interleukin-4 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002851">
<property type="term" value="P:positive regulation of peripheral T cell tolerance induction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002669">
<property type="term" value="P:positive regulation of T cell anergy"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032914">
<property type="term" value="P:positive regulation of transforming growth factor beta1 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048302">
<property type="term" value="P:regulation of isotype switching to IgG isotypes"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045589">
<property type="term" value="P:regulation of regulatory T cell differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002667">
<property type="term" value="P:regulation of T cell anergy"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006355">
<property type="term" value="P:regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030111">
<property type="term" value="P:regulation of Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0009615">
<property type="term" value="P:response to virus"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042110">
<property type="term" value="P:T cell activation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043029">
<property type="term" value="P:T cell homeostasis"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002456">
<property type="term" value="P:T cell mediated immunity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050852">
<property type="term" value="P:T cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002513">
<property type="term" value="P:tolerance induction to self antigen"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="CDD" id="cd00059">
<property type="entry name" value="FH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00497"/>
<dbReference type="InterPro" id="IPR001766">
<property type="entry name" value="Fork_head_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR032354">
<property type="entry name" value="FOXP-CC"/>
</dbReference>
<dbReference type="InterPro" id="IPR030456">
<property type="entry name" value="TF_fork_head_CS_2"/>
</dbReference>
<dbReference type="InterPro" id="IPR036388">
<property type="entry name" value="WH-like_DNA-bd_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR036390">
<property type="entry name" value="WH_DNA-bd_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013087">
<property type="entry name" value="Znf_C2H2_type"/>
</dbReference>
<dbReference type="Pfam" id="PF00250">
<property type="entry name" value="Forkhead"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF16159">
<property type="entry name" value="FOXP-CC"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00053">
<property type="entry name" value="FORKHEAD"/>
</dbReference>
<dbReference type="SMART" id="SM00339">
<property type="entry name" value="FH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF46785">
<property type="entry name" value="SSF46785"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00658">
<property type="entry name" value="FORK_HEAD_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50039">
<property type="entry name" value="FORK_HEAD_3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00028">
<property type="entry name" value="ZINC_FINGER_C2H2_1"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0219">Diabetes mellitus</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="Forkhead box protein P3" id="PRO_0000091886">
<location>
<begin position="1"/>
<end position="431"/>
</location>
</feature>
<feature type="chain" description="Forkhead box protein P3, C-terminally processed" id="PRO_0000432430" evidence="31">
<location>
<begin position="1"/>
<end position="417"/>
</location>
</feature>
<feature type="chain" description="Forkhead box protein P3 41 kDa form" id="PRO_0000432431" evidence="31">
<location>
<begin position="52"/>
<end position="417"/>
</location>
</feature>
<feature type="propeptide" id="PRO_0000432432" evidence="31">
<location>
<begin position="418"/>
<end position="431"/>
</location>
</feature>
<feature type="zinc finger region" description="C2H2-type">
<location>
<begin position="197"/>
<end position="222"/>
</location>
</feature>
<feature type="DNA-binding region" description="Fork-head" evidence="4">
<location>
<begin position="337"/>
<end position="423"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with ZFP90" evidence="22">
<location>
<begin position="106"/>
<end position="198"/>
</location>
</feature>
<feature type="region of interest" description="Essential for transcriptional repressor activity and for interaction with KAT5 and HDAC7" evidence="10">
<location>
<begin position="106"/>
<end position="190"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with IKZF4" evidence="3">
<location>
<begin position="149"/>
<end position="199"/>
</location>
</feature>
<feature type="region of interest" description="Leucine-zipper">
<location>
<begin position="239"/>
<end position="260"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with RUNX1" evidence="11">
<location>
<begin position="278"/>
<end position="336"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear export signal" evidence="19">
<location>
<begin position="68"/>
<end position="76"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL motif" evidence="12">
<location>
<begin position="92"/>
<end position="96"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear export signal" evidence="19">
<location>
<begin position="239"/>
<end position="248"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="19">
<location>
<begin position="414"/>
<end position="417"/>
</location>
</feature>
<feature type="site" description="Cleavage" evidence="15">
<location>
<begin position="51"/>
<end position="52"/>
</location>
</feature>
<feature type="site" description="Cleavage; by PCSK1 or PCSK2" evidence="15">
<location>
<begin position="417"/>
<end position="418"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK2" evidence="3">
<location>
<position position="19"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="18">
<location>
<position position="31"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="18">
<location>
<position position="263"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="18">
<location>
<position position="268"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="21">
<location>
<position position="418"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="3">
<location>
<position position="250"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="3">
<location>
<position position="252"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate" evidence="3">
<location>
<position position="263"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate" evidence="3">
<location>
<position position="268"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="3">
<location>
<position position="393"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 3." id="VSP_015796" evidence="26 28 29">
<location>
<begin position="72"/>
<end position="106"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_047859" evidence="27">
<location>
<begin position="246"/>
<end position="272"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_036418" evidence="29">
<original>K</original>
<variation>KVSSSEVAVTGMASSAIAAQSGQAWVWAHRHIGEERDVGCWWWLLASEVDAHLLPVPGLPQ</variation>
<location>
<position position="382"/>
</location>
</feature>
<feature type="sequence variant" description="In IPEX; mild phenotype; no loss of protein expression." id="VAR_078971" evidence="14">
<original>L</original>
<variation>P</variation>
<location>
<position position="242"/>
</location>
</feature>
<feature type="sequence variant" description="In IPEX; significantly reduces dimerization." id="VAR_011330" evidence="5 17">
<location>
<position position="251"/>
</location>
</feature>
<feature type="sequence variant" description="In IPEX; mild phenotype; no loss of protein expression; dbSNP:rs122467173." id="VAR_078972" evidence="14">
<original>F</original>
<variation>L</variation>
<location>
<position position="324"/>
</location>
</feature>
<feature type="sequence variant" description="In IPEX; no loss of protein expression; dbSNP:rs886044787." id="VAR_078973" evidence="14">
<original>P</original>
<variation>A</variation>
<location>
<position position="339"/>
</location>
</feature>
<feature type="sequence variant" description="In IPEX; mild phenotype; no loss of protein expression; impairs its ability to confer inhibitory function to regulatory T-cells; no loss of DNA-binding when associated with A-373; dbSNP:rs1557115786." id="VAR_078974" evidence="14 17">
<original>R</original>
<variation>H</variation>
<location>
<position position="347"/>
</location>
</feature>
<feature type="sequence variant" description="In IPEX." id="VAR_023569" evidence="8">
<original>I</original>
<variation>V</variation>
<location>
<position position="363"/>
</location>
</feature>
<feature type="sequence variant" description="In IPEX; no effect on dimerization; dbSNP:rs122467169." id="VAR_011331" evidence="6 17">
<original>F</original>
<variation>C</variation>
<location>
<position position="371"/>
</location>
</feature>
<feature type="sequence variant" description="In IPEX; requires 2 nucleotide substitutions; no loss of protein expression; disrupts dimerization; impairs its ability to confer inhibitory function to regulatory T-cells; no loss of DNA-binding when associated with H-347; dbSNP:rs122467172." id="VAR_078975" evidence="14 17">
<original>F</original>
<variation>A</variation>
<location>
<position position="373"/>
</location>
</feature>
<feature type="sequence variant" description="In IPEX; no loss of protein expression." id="VAR_078976" evidence="14">
<original>F</original>
<variation>C</variation>
<location>
<position position="374"/>
</location>
</feature>
<feature type="sequence variant" description="In IPEX; no loss of protein expression; dbSNP:rs122467170." id="VAR_011332" evidence="6 7 14">
<original>A</original>
<variation>T</variation>
<location>
<position position="384"/>
</location>
</feature>
<feature type="sequence variant" description="In IPEX; dbSNP:rs28935477." id="VAR_011333" evidence="6">
<original>R</original>
<variation>W</variation>
<location>
<position position="397"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease in nuclear export; when associated with A-71, A-74 and A-76." evidence="19">
<original>L</original>
<variation>A</variation>
<location>
<position position="69"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease in nuclear export; when associated with A-69, A-74 and A-76." evidence="19">
<original>L</original>
<variation>A</variation>
<location>
<position position="71"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease in nuclear export; when associated with A-69, A-71 and A-76." evidence="19">
<original>L</original>
<variation>A</variation>
<location>
<position position="74"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease in nuclear export; when associated with A-69, A-71 and A-74." evidence="19">
<original>L</original>
<variation>A</variation>
<location>
<position position="76"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with RORA." evidence="12">
<original>LL</original>
<variation>AA</variation>
<location>
<begin position="95"/>
<end position="96"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease in nuclear export; when associated with A-246 and A-248." evidence="19">
<original>L</original>
<variation>A</variation>
<location>
<position position="242"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease in nuclear export; when associated with A-242 and A-248." evidence="19">
<original>L</original>
<variation>A</variation>
<location>
<position position="246"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease in nuclear export; when associated with A-242 and A-246." evidence="19">
<original>L</original>
<variation>A</variation>
<location>
<position position="248"/>
</location>
</feature>
<feature type="mutagenesis site" description="No loss of DNA-binding. Disrupts dimerization but does not affect DNA-binding; when associated with T-370. Disrupts dimerization, does not affect DNA-binding, causes dysregulated expression of a subset of FOXP3 target genes and impairs its ability to confer inhibitory function to regulatory T-cells; when associated with T-370 and P-372." evidence="17">
<original>W</original>
<variation>Q</variation>
<location>
<position position="348"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts dimerization but does not affect DNA-binding; when associated with Q-348. Disrupts dimerization, does not affect DNA-binding, causes dysregulated expression of a subset of FOXP3 target genes and impairs its ability to confer inhibitory function to regulatory T-cells; when associated with Q-348 and P-372." evidence="17">
<original>M</original>
<variation>T</variation>
<location>
<position position="370"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts dimerization, does not affect DNA-binding, causes dysregulated expression of a subset of FOXP3 target genes and impairs its ability to confer inhibitory function to regulatory T-cells; when associated with Q-348 and T-370." evidence="17">
<original>A</original>
<variation>P</variation>
<location>
<position position="372"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of nuclear localization." evidence="19">
<original>KK</original>
<variation>EE</variation>
<location>
<begin position="415"/>
<end position="416"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease in phosphorylation, significant decrease in transcriptional repressor activity and reduced interaction with PP1CA, PP1CB and PP1CG. Significant decrease in phosphorylation and transcriptional repressor activity; when associated with A-422." evidence="21">
<original>S</original>
<variation>A</variation>
<location>
<position position="418"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slight increase in transcriptional repressor activity." evidence="21">
<original>S</original>
<variation>E</variation>
<location>
<position position="418"/>
</location>
</feature>
<feature type="mutagenesis site" description="Significant decrease in phosphorylation and transcriptional repressor activity; when associated with A-418." evidence="21">
<original>S</original>
<variation>A</variation>
<location>
<position position="422"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; CAA06748." ref="7" evidence="30">
<original>LGPSP</original>
<variation>MSPIS</variation>
<location>
<begin position="16"/>
<end position="20"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="342"/>
<end position="351"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="360"/>
<end position="371"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="372"/>
<end position="375"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="381"/>
<end position="391"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="395"/>
<end position="398"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="401"/>
<end position="403"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="405"/>
<end position="408"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="410"/>
<end position="416"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3QRF"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4WK8"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q99JB6"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00089"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11120765"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11137992"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11137993"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11768393"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15790681"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17360565"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17377532"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18354202"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18368049"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18951619"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19117830"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20676092"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21458306"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22312127"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22678915"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23169781"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23396208"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23543754"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23973222"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23973223"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25567984"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000303">
<source ref="3"/>
</evidence>
<evidence key="28" type="ECO:0000303">
<source ref="4"/>
</evidence>
<evidence key="29" type="ECO:0000303">
<source ref="7"/>
</evidence>
<evidence key="30" type="ECO:0000305"/>
<evidence key="31" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="19117830"/>
</source>
</evidence>
<sequence length="431" mass="47244" checksum="91737C3CEA665A15" modified="2001-06-01" version="1">MPNPRPGKPSAPSLALGPSPGASPSWRAAPKASDLLGARGPGGTFQGRDLRGGAHASSSSLNPMPPSQLQLPTLPLVMVAPSGARLGPLPHLQALLQDRPHFMHQLSTVDAHARTPVLQVHPLESPAMISLTPPTTATGVFSLKARPGLPPGINVASLEWVSREPALLCTFPNPSAPRKDSTLSAVPQSSYPLLANGVCKWPGCEKVFEEPEDFLKHCQADHLLDEKGRAQCLLQREMVQSLEQQLVLEKEKLSAMQAHLAGKMALTKASSVASSDKGSCCIVAAGSQGPVVPAWSGPREAPDSLFAVRRHLWGSHGNSTFPEFLHNMDYFKFHNMRPPFTYATLIRWAILEAPEKQRTLNEIYHWFTRMFAFFRNHPATWKNAIRHNLSLHKCFVRVESEKGAVWTVDELEFRKKRSQRPSRCSNPTPGP</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

